Shopping Cart (0)
My Account

Shopping Cart
3 for 2 Offer SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019Organ-on-a-Chip & Tissue-on-a-Chip Europe 2019Lab-on-a-Chip & Microfluidics Europe 2019Biofabrication & Biomanufacturing Europe 2019ePoster Award Prize

Business Courses

Epigenetics, Reprogramming, Induced Pluripotent Stem Cells (iPSCs) and Cancer Stem Cells (CSCs): Technology and Market Analysis for Research, Drug Discovery, and Therapeutics Development

This Business Course is being held in Yokohama, Japan in parallel with ISSCR2012 on the 15 June 2012 at 16:00 - 19:00


Enal Razvi Image
Enal Razvi
Managing Director,
Select Biosciences Inc
Akiko Futamura Image
Akiko Futamura
President and Chief Executive Officer,

Select Biosciences is hosting this market tutorial as a means to provide an up-to-date analysis of the stem cell commercial space.  Attendees of ISSCR 2012 will find this tutorial extremely informative for business planning purposes and to assess the market opportunity in the various stem cell market segments, thereby ensuring a very cost-effective trip to Yokohama.  All tutorial attendees receive a CD loaded with market analysis data for their in-house use.


Chinese (Traditional)

Chinese (simplified)


Scope of this Market Tutorial

This tutorial is designed to provide a comprehensive analysis of the field of epigenetics and cellular reprogramming as they are impacting the broader stem cells research space in a profound manner vis-à-vis the generation of induced pluripotent stem cells (iPSCs).  This tutorial examines the technical as well as commercial aspects of the iPSCs space illustrating methodologies for generation, features/benefits of various methods for generation, end-user applications in research, drug discovery screening, and market potential for therapeutics in the future.

This tutorial also presents an analysis of the cancer stem cells (CSCs) space—their biology, characterization, market trends, and clinical trials pipeline.  In this manner, this course synthesizes detailed information relating to two of the key areas of intensive research in the broader stem cells space: iPSCs and CSCs.

Epigenetics, Reprogramming, iPSCs

-    Biological Significance and Role of Epigenetics in the Stem Cells Field
-    Methods of Reprogramming
o    Safe versus Unsafe Reprogramming
o    Clinically-relevant Reprogramming
-    iPSC Characterization Methodologies
-    iPSC Research Marketplace: Vendors offering products, quantitative market shares, market sizing, and growth rates
-    iPSCs for Drug Discovery and Toxicity Screening:  Vendors offering products, quantitative market shares, market sizing, and growth rates
-    iPSCs for Therapeutics: Market drivers, therapeutics areas, and opportunities, convergence with hESCs

Cancer Stem Cells

-    Biological Relevance
-    Molecular Mechanisms in vivo
-    Research Trends
-    Clinical Trials Analysis

This course draws upon primary research data collected by Select Biosciences as part of its continuing tracking of the various segments of the stem cells marketplace and focuses on qualitative as well as quantitative analysis of the space.

This market tutorial is ideally suited for researchers involved in investigations focusing on pluripotent stem cells—both academic as well as from the industrial community. Also, this course is important for biotechnology, pharmaceutical, and related disciplines wherein industry participants—both technically focused as well as business focused—can get a solid understanding of the marketplace as well as receive the most up-to-date market data and associated materials for in-house research and business planning activities.  Also, this course is recommended for investors as well as attorneys looking for a current technology and market review of this expanding field.

Specific Presentation Topics

  • Epigenetic modifications in vivo and their significance
  • Reprogramming methodologies and their intersection with epigenetic pathways in vivo
    o    Safe versus Unsafe Reprogramming
    o    Clinically-relevant Reprogramming
  • Requirements for clinical-grade iPSCs
  • What are the diagnostic tests for iPSCs currently?
  • Therapeutic areas where iPSCs have relevance for the future
  • Grant funding in the iPSCs space and niches of opportunity
  • Life science research on iPSCs
    o    Technologies/Products
    o    Vendors
    o    Market Shares
    o    Market Size
    o    Growth Rate
  • Drug Discovery Screening
    o    Segments where iPSCs offer value
    o    Vendors and Products
    o    Quantitative Market Penetrance
    o    Quantitative Market Opportunity
  • Cancer Stem Cells (CSCs)
    o    Biological relevance in vivo
    o    Molecular characteristics
    o    Research trends
  • Markers Used
  • o    Clinical Trials on CSCs

For more information about this market tutorial or for group registrations, please e-mail Kathy Gray at